digiMedical Solutions, Inc.(TM) Focuses on New Sales Channels With Launch of digiRX Digital Prescription Web Portal
April 29 2009 - 12:52PM
Marketwired
digiMedical Solutions, Inc.(TM) (PINKSHEETS: DGMS) today launched a
website that will be the focal point of the services offered by
digiMedical's product digiRX(TM). The new website can be reviewed
at www.digirx.com.
digiRX(TM) is an acute care digital medical software system that
provides services to physicians, patients and pharmacies. The
digiRX(TM) software addresses the movement of prescriptions from
the physician's office to the pharmacy, with a focus on controlling
the movement of Schedule II drugs, such as OxiContin. digiRX(TM) is
a thin-client system thus allowing updates to be instantaneous to
the end users. "Thin-client" means that users only need an Internet
browser to access the product. digiRX(TM) has ancillary services
providing detailed history to nurses, physicians and pharmacists
and the means to transmit prescriptions securely to any
pharmacy.
To learn more about digiRX(TM) or any of the Company's digital
medical software products, please contact the company at
sales@digimedical.com or (817) 503-8880 x 111. To be added to
digiMedical's corporate e-mail list to receive company updates,
please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)
digiMedical Solutions, Inc.(TM) is a pharmacy and medical
technology company focused on developing next generation, digital
medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that closely align the doctor, pharmacist and
patient. The company's planned growth will come from three
channels: direct marketing of the company's wireless based
d-prescription technology to physicians, direct marketing of the
company's digital call center services for refills and
reauthorization and partnering with independent pharmacy chains to
focus sales with the technology suite.
Forward-Looking Statement
Statements included in this press release which are not
historical in nature, are intended to be, and are hereby identified
as "Forward-Looking Statements" for purposes of safe harbor
provided by Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-Looking Statements may be identified by words
including "anticipate," "await," "envision," "foresee," "aim at,"
"believe," "intends," "estimates" including without limitation,
those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's
filings with the U.S. Securities and Exchange Commission.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: digiMedical Solutions, Inc. Investor Relations
214-722-3029 ir@digimedical.com www.digimedical.com
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From May 2024 to Jun 2024
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From Jun 2023 to Jun 2024